Back to People & Entities
InterCept Pharmaceuticals
Organization
1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
Document Mentions (1)
New Leaf Ventures III LP - PPM (Control 257 - Boris Nicolik).pdf
1 mentionHOUSE_OVERSIGHT_024003_sub_001 - HOUSE_OVERSIGHT_024102
Source: House Oversight Committee
cs (NLV-II, private initially, now public on NASDAQ: DRTX), Phase III, focused on a late stage antibiotic development program spun out of Pfizer, and InterCept Pharmaceuticals (NLV-II, NASDAQ: ICPT, exited at 3.2x), Phase III, focused on an orphan indication in liver disease. e Investments in public companies at any stage,
Sponsored
Connected Entities
No connected entities